GlycoBac

NIH awards 8

Annual award amounts. Total $2.4M.

• Feb 28, 2020 NIH award 1R43GM136071-01 FY2020: $224,597 awarded for that fiscal year; activity R43 (SBIR); PI BLAIR, CAROL D; recipient as written: GLYCOBAC, LLC, LARAMIE, WY. Insect cell lines for glycoprotein structural biology source ↗
• Feb 26, 2018 NIH award 1R43GM125397-01A1 FY2018: $217,385 awarded for that fiscal year; activity R43 (SBIR); PI BLAIR, CAROL D; recipient as written: GLYCOBAC, LLC, LARAMIE, WY. Engineering a new insect cell line for human-type p source ↗
• Aug 28, 2017 NIH award 5R44GM102982-04 FY2017: $493,407 awarded for that fiscal year; activity R44 (SBIR); PI BLAIR, CAROL D; recipient as written: GLYCOBAC, LLC, LARAMIE, WY. Glycoengineered insect cells for commercial biologics source ↗
• Aug 12, 2016 NIH award 2R44GM102982-03 FY2016: $446,173 awarded for that fiscal year; activity R44 (SBIR); PI GEISLER, CHRISTOPH; recipient as written: GLYCOBAC, LLC, LARAMIE, WY. Glycoengineered insect cells for commercial biolo source ↗
• Jul 30, 2014 NIH award 5R43GM102982-02 FY2014: $296,812 awarded for that fiscal year; activity R43 (SBIR); PI GEISLER, CHRISTOPH; recipient as written: GLYCOBAC, LLC, LARAMIE, WY. Glycoengineering insect cells for commercial reco source ↗
• May 19, 2014 NIH award 1R43AI112118-01 FY2014: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI MAGHODIA, AJAYKUMAR B.; recipient as written: GLYCOBAC, LLC, LARAMIE, WY. Glycoengineered baculoviruses for the product source ↗
• Feb 27, 2014 NIH award 1R43GM109504-01 FY2014: $148,202 awarded for that fiscal year; activity R43 (SBIR); PI GEISLER, CHRISTOPH; recipient as written: GLYCOBAC, LLC, LARAMIE, WY. Engineering cells for concurrent protein drug bio source ↗
• Sep 11, 2013 NIH award 1R43GM102982-01A1 FY2013: $302,429 awarded for that fiscal year; activity R43 (SBIR); PI GEISLER, CHRISTOPH; recipient as written: GLYCOBAC, LLC, LARAMIE, WY. Glycoengineering insect cells for commercial re source ↗